Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 6, 2012, Pages 521-527

  Amirjani, Nasim ^a,b   Kiernan, Matthew C ^a,b   McKenzie, David K ^b   Butler, Jane E ^a   Gandevia, Simon C ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Amyotrophic lateral sclerosis (ALS); Diaphragm; Motor neuron; Pacing; Phrenic nerve

Indexed keywords

ADVERSE OUTCOME; AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; CLINICAL EFFECTIVENESS; COMPOUND MUSCLE ACTION POTENTIAL; ELECTRODE; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; ELECTROSTIMULATION THERAPY; HUMAN; MOTONEURON; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE INJURY; NONHUMAN; PHRENIC NERVE; PHRENIC NERVE PACING; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SAFETY; SURVIVAL RATE; SURVIVAL TIME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DIAPHRAGM; DISEASE PROGRESSION; HUMANS; MUSCLE CONTRACTION; RESPIRATORY INSUFFICIENCY;

EID: 84866107015     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.673169     Document Type: Review

References (69)

1. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59-62.
2. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942-55.
3. Cheah BC, Boland RA, Brodaty NE, Zoing MC, Jeffery SE, McKenzie DK, et al. INSPIRATIonAL-INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:384-92.
4. FDA; HDE approvals. http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsand Clearances/HDEApprovals/default. htm.
5. Onders RP, Elmo M, Khansarinia S, Bowman B, Yee J, Road J, et al. Complete worldwide operative experience in laparoscopic diaphragm pacing: Results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc. 2009;23:1433-40.
6. Glenn WW, Hageman JH, Mauro A, Eisenberg L, Flanigan S, Harvard M. Electrical stimulation of excitable tissue by radiofrequency transmission. Ann Surg. 1964;160:338-50.
7. Judson JP, Glenn WW. Radio-frequency electrophrenic respiration. Long-term application to a patient with primary hypoventilation. JAMA. 1968;203:1033-7.
8. Glenn WW. On diaphragm pacing. N Engl J Med. 1987; 317:1477-8.
9. Glenn WW, Phelps ML, Elefteriades JA, Dentz B, Hogan JF. Twenty years of experience in phrenic nerve stimulation to pace the diaphragm. Pacing Clin Electrophysiol. 1986;9: 780-4.
10. Elefteriades JA, Quin JA, Hogan JF, Holcomb WG, Letsou GV, Chlosta WF, et al. Long-term follow-up of pacing of the conditioned diaphragm in quadriplegia. Pacing Clin Electrophysiol. 2002;25:897-906.
11. Khong P, Lazzaro A, Mobbs R. Phrenic nerve stimulation: the Australian experience. J Clin Neurosci. 2010;17:205-8.
12. Glenn WW, Phelps ML. Diaphragm pacing by electrical stimulation of the phrenic nerve. Neurosurgery. 1985;17: 974-84.
13. Shaul DB, Danielson PD, McComb JG, Keens TG. Thoracoscopic placement of phrenic nerve electrodes for diaphragmatic pacing in children. J Pediatr Surg. 2002;37:974-8.
14. Thoma H, Gerner H, Holle J, Kluger P, Mayr W, Meister B, et al. The phrenic pacemaker: substitution of paralysed functions in tetraplegia. ASAIO Trans. 1987;33:472-9.
15. Kim JH, Manuelidis EE, Glenn WW, Fukuda Y, Cole DS, Hogan JF. Light and electron microscopic studies of phrenic nerves after long-term electrical stimulation. J Neurosurg. 1983;58:84-91.
16. Le Pimpec-Barthes F, Gonzalez-Bermejo J, Hubsch JP, Duguet A, Morelot-Panzini C, Riquet M, et al. Intrathoracic phrenic pacing: A 10-year experience in France. J Thorac Cardiovasc Surg. 2011;142:378-83.
17. Garrido-Garcia H, Mazaira Alvarez J, Martin Escribano P, Romero Ganuza J, La Banda F, Gambarrutta C, et al. Treatment of chronic ventilatory failure using a diaphragmatic pacemaker. Spinal Cord. 1998;36:310-4.
18. Weese-Mayer DE, Morrow AS, Brouillette RT, Ilbawi MN, Hunt CE. Diaphragm pacing in infants and children: A lifetable analysis of implanted components. Am Rev Respir Dis. 1989;139:974-9.
19. DiMarco AF, Onders RP, Kowalski KE, Miller ME, Ferek S, Mortimer JT. Phrenic nerve pacing in a tetraplegic patient via intramuscular diaphragm electrodes. Am J Respir Crit Care Med. 2002;166:1604-6.
20. Onders RP, DiMarco AF, Ignagni AR, Mortimer JT. The learning curve for investigational surgery: lessons learned from laparoscopic diaphragm pacing for chronic ventilator dependence. Surg Endosc. 2005;19:633-7.
21. Onders RP, Dimarco AF, Ignagni AR, Aiyar H, Mortimer JT. Mapping the phrenic nerve motor point: the key to a successful laparoscopic diaphragm pacing system in the fi rst human series. Surgery. 2004;136:819-26.
22. Gonzalez-Bermejo J, Morelot-Panzini C, Salachas F, Redolfi S, Straus C, Becquemin MH, et al. Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:44-54.
23. Shaw RK, Glenn WW, Hogan JF, Phelps ML. Electrophysiological evaluation of phrenic nerve function in candidates for diaphragm pacing. J Neurosurg. 1980;53:345-54.
24. McKenzie DK, Gandevia SC. Phrenic nerve conduction times and twitch pressures of the human diaphragm. J Appl Physiol. 1985;58:1496-504.
25. Mills GH, Kyroussis D, Hamnegard CH, Wragg S, Moxham J, Green M. Unilateral magnetic stimulation of the phrenic nerve. Thorax. 1995;50:1162-72.
26. Nochomovitz ML, Dimarco AF, Mortimer JT, Cherniack NS. Diaphragm activation with intramuscular stimulation in dogs. Am Rev Respir Dis. 1983;127:325-9.
27. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495-520.
28. Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66:647-53.
29. Soraru G, Ermani M, Logroscino G, Palmieri A, D'Ascenzo C, Orsetti V, et al. Natural history of upper motor neurondominant ALS. Amyotroph Lateral Scler. 2010;11:424-9.
30. Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol. 2007;64:232-6.
31. Llado J, Haenggeli C, Pardo A, Wong V, Benson L, Coccia C, et al. Degeneration of respiratory motor neurons in the SOD1-G93A transgenic rat model of ALS. Neurobiol Dis. 2006;21:110-8.
32. Sathyaprabha TN, Pradhan C, Nalini A, Thennarasu K, Raju TR. Pulmonary function tests and diaphragmatic compound muscle action potential in patients with sporadic amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;121:400-5.
33. Bradley WG, Good P, Rasool CG, Adelman LS. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol. 1983;14:267-77.
34. Summary of safety and probable benefi t (SSPB). http:// www.accessdata.fda.gov/cdrh-docs/pdf10/H100006b.pdf.
35. Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: Prognostic indicators of survival. Amyotroph Lateral Scler. 2006;7:211-20.
36. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: A population based study. Neurology. 2003;60:813-9.
37. Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10:310-23.
38. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Predictors of long survival in amyotrophic lateral sclerosis: A population based study. J Neurol Sci. 2008;268:28-32.
39. Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the fl ail arm and fl ail leg ALS variants. Neurology. 2009;72:1087-94.
40. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman- Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999; 164:82-8.
41. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update. The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73: 1218-26.
42. Winhammar JM, Rowe DB, Henderson RD, Kiernan MC. Assessment of disease progression in motor neuron disease. Lancet Neurol. 2005;4:229-38.
43. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomized controlled trial. Lancet Neurol. 2006; 5:140-7.
44. David WS, Bundlie SR, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. J Neurol Sci. 1997;152: S29-35.
45. Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler. 2007;8:185-8.
46. Chio A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: A 10-year population based study. J Neurol Neurosurg Psychiatry. 2011. Epub ahead of print
47. Carratu P, Spicuzza L, Cassano A, Maniscalco M, Gadaleta F, Lacedonia D, et al. Early treatment with non-invasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insuffi - ciency. Orphanet J Rare Dis. 2009;4:10.
48. Mustfa N, Walsh E, Bryant V, Lyall RA, Addington-Hall J, Goldstein LH, et al. The effect of non-invasive ventilation on ALS patients and their caregivers. Neurology. 2006;66: 1211-7.
49. Peysson S, Vandenberghe N, Philit F, Vial C, Petitjean T, Bouhour F, et al. Factors predicting survival following non-invasive ventilation in amyotrophic lateral sclerosis. Eur Neurol. 2008;59:164-71.
50. Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Non-invasive positive-pressure ventilation in ALS: Predictors of tolerance and survival. Neurology. 2006;67:761-5.
51. Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, et al. Rapid disuse atrophy of diaphragm fi bres in mechanically ventilated humans. N Engl J Med. 2008;358:1327-35.
52. Powers SK, Kavazis AN, Levine S. Prolonged mechanical ventilation alters diaphragmatic structure and function. Crit Care Med. 2009;37:S347-53.
53. Onders RP, Carlin AM, Elmo M, Sivashankaran S, Katirji B, Schilz R. Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anaesthesia can be safely performed. Am J Surg. 2009;197:386-90.
54. Amirjani N, Gandevia SC. Comments on 'D iaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis ' . Amyotroph Lateral Scler. 2012;13:243-44.
55. Schmiesing CA, Lee J, Morton JM, Brock-Utne JG. Laparoscopic diaphragmatic pacer placement: A potential new treatment for ALS patients: A brief description of the device and anaesthetics issues. J Clin Anesth. 2010;22:549-52.
56. Lepore AC, Tolmie C, O'Donnell J, Wright MC, Dejea C, Rauck B, et al. Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiol Dis. 2010;39:252-64.
57. Metzger JM, Scheidt KB, Fitts RH. Histochemical and physiological characteristics of the rat diaphragm. J Appl Physiol. 1985;58:1085-91.
58. Moxham J, Morris AJ, Spiro SG, Edwards RH, Green M. Contractile properties and fatigue of the diaphragm in man. Thorax. 1981;36:164-8.
59. Aubier M, Farkas G, de Troyer A, Mozes R, Roussos C. Detection of diaphragmatic fatigue in man by phrenic stimulation. J Appl Physiol. 1981;50:538-44.
60. de Troyer A, Leeper JB, McKenzie DK, Gandevia SC. Neural drive to the diaphragm in patients with severe COPD. Am J Respir Crit Care Med. 1997;155:1335-40.
61. Ciesielski TE, Fukuda Y, Glenn WW, Gorfi en J, Jeffery K, Hogan JF. Response of the diaphragm muscle to electrical stimulation of the phrenic nerve. A histochemical and ultrastructural study. J Neurosurg. 1983;58:92-100.
62. Vucic S, Kiernan MC. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med. 2009;9:255-72.
63. Grosskreutz J, van den Bosch L, Keller BU. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47:165-74.
64. Heath PR, Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:438-58.
65. David G, Barrett EF. Stimulation-evoked increases in cytosolic [Ca(2 -) ] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperaturedependent. J Neurosci. 2000;20:7290-6.
66. Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29:656-62.
67. Carreras I, Yuruker S, Aytan N, Hossain L, Choi JK, Jenkins BG, et al. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res. 2010;1313: 192-201.
68. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is benefi cial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003;53:804-7.
69. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140:691-707.